Synthesis and Evaluation of an Intercalator–Polyamide Hairpin Designed to Target the Inverted CCAAT Box 2 in the Topoisomerase IIα Promoter

The synthesis and DNA‐binding properties of a novel naphthalimide–polyamide hairpin (3) designed to target the inverted CCAAT box 2 (ICB2) site on the topoisomerase IIα (topoIIα) promoter are described. The polyamide component of 3 was derived from the minor‐groove binder, 2, and tailored to bind to the 5′‐TTGGT sequence found in and flanking ICB2. The propensity of mitonafide 4 to intercalate between G–C base pairs was exploited by the incorporation of a naphthalimide moiety at the N terminus of 2. Hybrid 3 targeted 5′‐CGATTGGT and covered eight contiguous base pairs, which included the underlined ICB2 site. DNase I footprinting analysis with the topoIIα promoter sequence demonstrated that 3 bound selectively to the ICB2 and ICB3 sites. Thermal‐denaturation studies confirmed these results, and the highest degree of stabilization was found for ICB2 and ‐3 in preference to ICB1 (4.1, 4.6, and 0.6 °C, respectively). CD studies confirmed minor‐groove binding and suggested a 1:1 binding stoichiometry. Emission‐titration experiments established intercalative binding. Surface plasmon resonance results showed strong binding to ICB2 (2.5×107 M−1) with no observable binding to ICB1. Furthermore, the binding constant of 3 to ICB2 was larger than that of the parent polyamide 2. The increased binding affinity was primarily due to a reduction in the dissociation‐rate constant of the polyamide–DNA complex, which can be attributed to the N‐terminal naphthalimide moiety. In addition, the binding site of 3 was larger than that of 2, which innately improved sequence selectivity. We conclude that the polyamide–naphthalimide 3 selectively binds to the ICB2 site by simultaneous intercalation and minor‐groove binding, and warrants further investigation as a model compound for the regulation of topoIIα gene expression.

[1]  Carly A. Price,et al.  Influence of a terminal formamido group on the sequence recognition of DNA by polyamides. , 2002, Journal of the American Chemical Society.

[2]  R. Bürli,et al.  Sequence-specific DNA recognition by polyamides. , 1999, Current opinion in chemical biology.

[3]  A. Harris,et al.  Regulation of the Human Topoisomerase IIα Gene Promoter in Confluence-arrested Cells* , 1996, The Journal of Biological Chemistry.

[4]  C. Bailly,et al.  Effects of two distamycin-ellipticine hybrid molecules on topoisomerase I and II mediated DNA cleavage: relation to cytotoxicity. , 1995, Biochemical pharmacology.

[5]  P. Dervan,et al.  Inhibition of Moloney murine leukemia virus integration using polyamides targeting the long-terminal repeat sequences. , 2003, Biochemistry.

[6]  M. D. Fontaine,et al.  Structure-activity relationship of a series of C-terminus modified aminoalkyl, diaminoalkyl- and anilino-containing analogues of the benzoic acid mustard distamycin derivative tallimustine: synthesis, DNA binding and cytotoxicity studies. , 1997, Bioorganic & medicinal chemistry.

[7]  A. Wang,et al.  Imidazole-imidazole pair as a minor groove recognition motif for T:G mismatched base pairs. , 1999, Nucleic acids research.

[8]  W. Wilson,et al.  Energetic basis for selective recognition of T*G mismatched base pairs in DNA by imidazole-rich polyamides. , 2004, Nucleic acids research.

[9]  D E Wemmer,et al.  Designed sequence-specific minor groove ligands. , 2000, Annual review of biophysics and biomolecular structure.

[10]  W. David Wilson,et al.  Analyzing Biomolecular Interactions , 2002, Science.

[11]  A. Ramos,et al.  Naphthalimides as anti-cancer agents: synthesis and biological activity. , 2001, Current medicinal chemistry. Anti-cancer agents.

[12]  A. Wang,et al.  Structural studies of atom-specific anticancer drugs acting on DNA. , 1999, Pharmacology & therapeutics.

[13]  C. Bailly,et al.  Molecular recognition between oligopeptides and nucleic acids. DNA sequence specificity and binding properties of an acridine‐linked netropsin hybrid ligand , 1990, Journal of molecular recognition : JMR.

[14]  Koichi Matsumoto,et al.  Synthetic Pyrrole-Imidazole Polyamide Inhibits Expression of the Human Transforming Growth Factor-β1 Gene , 2005, Journal of Pharmacology and Experimental Therapeutics.

[15]  J. Trauger,et al.  Recognition of DNA by designed ligands at subnanomolar concentrations , 1996, Nature.

[16]  P. Dervan,et al.  Recognition of the DNA minor groove by pyrrole-imidazole polyamides. , 2003, Current opinion in structural biology.

[17]  Christina M. Taylor,et al.  Allosteric inhibition of zinc-finger binding in the major groove of DNA by minor-groove binding ligands. , 2004, Biochemistry.

[18]  D M Crothers,et al.  Studies of the binding of actinomycin and related compounds to DNA. , 1968, Journal of molecular biology.

[19]  Christian Melander,et al.  Regulation of gene expression with pyrrole-imidazole polyamides. , 2004, Journal of biotechnology.

[20]  P. Dervan,et al.  Hairpin Peptide Motif. A New Class of Oligopeptides for Sequence-Specific Recognition in the Minor Groove of Double-Helical DNA , 1994 .

[21]  B. Nordén,et al.  The CD of ligand‐DNA systems. 2. Poly(dA‐dT) B‐DNA , 1991, Biopolymers.

[22]  O. Billet,et al.  Inhibition of feline immunodeficiency virus (FIV) replication by DNA binding polyamides. , 2002, Bioorganic & medicinal chemistry letters.

[23]  J. Trauger,et al.  Extension of sequence-specific recognition in the minor groove of DNA by pyrrole-imidazole polyamides to 9-13 base pairs , 1996 .

[24]  M. Bellorini,et al.  CCAAT-box binding protein NF-Y (CBF, CP1) recognizes the minor groove and distorts DNA. , 1995, Nucleic acids research.

[25]  Binh Nguyen,et al.  Targeting the inverted CCAAT box 2 in the topoisomerase IIalpha promoter by JH-37, an imidazole-pyrrole polyamide hairpin: design, synthesis, molecular biology, and biophysical studies. , 2004, Biochemistry.

[26]  Karen L. Buchmueller,et al.  Extending the language of DNA molecular recognition by polyamides: unexpected influence of imidazole and pyrrole arrangement on binding affinity and specificity. , 2005, Journal of the American Chemical Society.

[27]  Noboru Fukuda,et al.  Development of gene silencing pyrrole-imidazole polyamide targeting the TGF-beta1 promoter for treatment of progressive renal diseases. , 2006, Journal of the American Society of Nephrology : JASN.

[28]  D. Hochhauser,et al.  Transcriptional regulation of topoisomerase II alpha at confluence and pharmacological modulation of expression by bis-benzimidazole drugs. , 2001, Molecular pharmacology.

[29]  M. Waring,et al.  Binding of a distamycin-ellipticine hybrid molecule to DNA and chromatin: spectroscopic, biochemical, and molecular modeling investigations. , 1992, Biochemistry.

[30]  P. Dervan,et al.  Allosteric inhibition of protein--DNA complexes by polyamide--intercalator conjugates. , 2003, Journal of the American Chemical Society.

[31]  J. Feigon,et al.  Interactions of antitumor drugs with natural DNA: 1H NMR study of binding mode and kinetics. , 1984, Journal of medicinal chemistry.

[32]  P. Wright,et al.  Inhibition of DNA binding by human estrogen-related receptor 2 and estrogen receptor alpha with minor groove binding polyamides. , 2005, Biochemistry.

[33]  J. Lepecq,et al.  A fluorescent complex between ethidium bromide and nucleic acids. Physical-chemical characterization. , 1967, Journal of molecular biology.

[34]  D S Goodsell,et al.  Defining GC-specificity in the minor groove: side-by-side binding of the di-imidazole lexitropsin to C-A-T-G-G-C-C-A-T-G. , 1997, Structure.

[35]  C. Bailly,et al.  Biological activity and molecular interaction of a netropsin-acridine hybrid ligand with chromatin and topoisomerase II. , 1992, Biochemical pharmacology.